Immunogenicity and safety evaluation of a newly manufactured recombinant Baculovirus-Expressed quadrivalent influenza vaccine in adults 18 years old and Above: An Open-Label, phase III extension study
| Autor: | Shahri, Mohammad Saleh, Sadeghi, Setayesh, Hazegh Fetratjoo, Delara, Hosseini, Hamed, Amin Ghobadi, Mohammad, Afshani, Seyyedeh Maryam, Mirhassani, Reihaneh, Gohari, Kimiya, Havasi, Forugh, Abdolghaffari, Amirhossein, Hedayatjoo, Behnaz, Ghanei, Mostafa |
|---|---|
| Zdroj: | In International Immunopharmacology 30 July 2024 136 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect